Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
Clinical trial NCT05371496 · COMPLETED
Trial details
- NCT number
- NCT05371496
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2026-07-17
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.